TRYP:LSE:LSE-HANetf ICAV - The Travel UCITS ETF (USD)

ETF | Others |

Last Closing

USD 7.1925

Change

+0.01 (+0.09)%

Market Cap

USD 0.02B

Volume

2.68K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-11 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

-19.50 (-10.40%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

-9.29 (-8.11%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.84 (-6.10%)

USD 543.17B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-1.04 (-5.94%)

USD 543.17B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+0.75 (+1.12%)

USD 266.08B
0QZO:LSE 0QZO

-3.35 (-3.60%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

-5.87 (-3.50%)

USD 202.26B
PRJU:LSE Amundi Index Solutions - Amund..

-1.77 (-5.93%)

USD 198.36B
0R24:LSE Intel Corp.

N/A

USD 196.14B

ETFs Containing TRYP:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.47% 39% F 45% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.47% 37% F 44% F
Trailing 12 Months  
Capital Gain 0.85% 21% F 35% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.85% 19% F 35% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 7.75% 63% D 66% D+
Dividend Return 7.75% 62% D 65% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.67% 57% F 73% C
Risk Adjusted Return 66.43% 77% C+ 85% B
Market Capitalization 0.02B 23% F 17% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.